Abbott secures expanded FDA approval for Infinity DBS System
Abbott’s DBS system has been developed to offer directed stimulation to areas of the brain to optimise patient…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Jan 20
Abbott’s DBS system has been developed to offer directed stimulation to areas of the brain to optimise patient…
22 Jan 20
The company's Intellis platform is designed to address the constraints associated with the available SCS systems, and is…
22 Jan 20
Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary…
17 Jan 20
KITE is the research arm of the Toronto Rehabilitation Institute and one of the principle research enterprises at…
10 Jan 20
Percept PC neurostimulator is claimed to be the only Deep Brain Stimulation (DBS) system commercially available in the…
10 Jan 20
Pear’s reSET-O is the first US FDA-authorized Prescription Digital Therapeutic for patients with Opioid Use Disorder
20 Dec 19
The Axonics patent portfolio represents technology internally developed by Axonics and technology developed under license from the Alfred…
18 Dec 19
Technology for social good start-ups specialising in energytech, healthtech and envirotech pitched their innovations at the Unbound London…
Patient Care DevicesPatient Care MonitoringDiagnostic Devices
17 Dec 19
Transcranial Magnetic Stimulation at Capital Health - Behavioral Health Specialists
17 Dec 19
The partnership is expected to provide specialist neurological rehabilitation services